HealthEquity (NASDAQ:HQY) EVP Sells $138,105.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction dated Monday, October 20th. The shares were sold at an average price of $92.07, for a total transaction of $138,105.00. Following the transaction, the executive vice president owned 76,979 shares of the company’s stock, valued at $7,087,456.53. This trade represents a 1.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Delano Ladd also recently made the following trade(s):

• On Friday, September 19th, Delano Ladd sold 6,000 shares of HealthEquity stock. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00.

HealthEquity Price Performance

HealthEquity stock opened at $96.50 on Friday. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65. The stock has a market capitalization of $8.31 billion, a P/E ratio of 58.49, a P/E/G ratio of 1.39 and a beta of 0.47. The firm’s 50-day moving average is $92.21 and its two-hundred day moving average is $94.47. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The company had revenue of $325.80 million for the quarter, compared to analysts’ expectations of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Royal Bank Of Canada raised their price target on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 3rd. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. JPMorgan Chase & Co. raised their target price on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 3rd. Barrington Research reissued an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. Finally, Jefferies Financial Group raised their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $121.31.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Nisa Investment Advisors LLC lifted its position in HealthEquity by 2.9% during the second quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company’s stock valued at $397,000 after buying an additional 108 shares in the last quarter. Advisors Asset Management Inc. lifted its position in HealthEquity by 4.7% during the second quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company’s stock valued at $255,000 after buying an additional 110 shares in the last quarter. Ieq Capital LLC lifted its position in HealthEquity by 4.4% during the first quarter. Ieq Capital LLC now owns 2,945 shares of the company’s stock valued at $260,000 after buying an additional 123 shares in the last quarter. Xponance Inc. lifted its position in HealthEquity by 1.1% during the first quarter. Xponance Inc. now owns 12,412 shares of the company’s stock valued at $1,097,000 after buying an additional 136 shares in the last quarter. Finally, Coldstream Capital Management Inc. lifted its position in HealthEquity by 7.3% during the second quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company’s stock valued at $212,000 after buying an additional 138 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.